About: Andreas Hochhaus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Andreas Hochhaus Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) ricercatore (it) গবেষক (bn) 研究者 (ja) investigador (es) chercheur (fr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq) researcher (en-ca) researcher (en-gb) researcher (en-us) investigador (ca) investigador (gl) investigador (ast) investigador (pt)
exact match	wds:Q37829812-D1CC5C5A-C031-4F1F-852D-10F9B3BE642E
exact match	https://scigraph.springernature.com/person.01064615503.48
rdfs:label	Andreas Hochhaus (en) Andreas Hochhaus (es) Andreas Hochhaus (it) Andreas Hochhaus (nl) Andreas Hochhaus (sl) Andreas Hochhaus (ast)
skos:prefLabel	Andreas Hochhaus (en) Andreas Hochhaus (es) Andreas Hochhaus (it) Andreas Hochhaus (nl) Andreas Hochhaus (sl) Andreas Hochhaus (ast)
name	Andreas Hochhaus (en) Andreas Hochhaus (es) Andreas Hochhaus (it) Andreas Hochhaus (nl) Andreas Hochhaus (sl) Andreas Hochhaus (ast)
Scopus author ID	wds:Q37829812-C02AF505-0AD7-49AD-8E2B-92A12820F1A9
Scopus author ID	35406412600
given name	wds:Q37829812-69617FA5-7C79-46A9-86C8-AF6C0D87BA97
given name	Andreas
instance of	wds:Q37829812-468BED2B-45F1-4C71-99A0-02D09411AE91
instance of	Homo sapiens
occupation	wds:Q37829812-791B5A1D-3C8F-4521-80B3-09AF9C286D28
sex or gender	wds:Q37829812-C1552CF9-0E3B-4926-A2BB-F9FC44BE4FBC
VIAF ID	wds:Q37829812-4CD59FEB-4554-44C3-B782-C7E0D5EB156F
GND ID	wds:Q37829812-633f4229-e60a-4f36-a801-e3d7d7395f20
member of	wds:Q37829812-2E84FD19-9E24-485A-B35E-22ADB93DA59D
WorldCat Identities ID (superseded)	wds:Q37829812-FCF7B70D-AD32-4E06-81AE-1D09016B3ADC
VIAF ID	http://viaf.org/viaf/104146937804213831855
GND ID	https://d-nb.info/gnd/1107039339
occupation	researcher
sex or gender	male
VIAF ID	104146937804213831855
GND ID	1107039339
member of	Saxon Academy of Sciences and Humanities
WorldCat Identities ID (superseded)	viaf-104146937804213831855
ORCID iD	wds:Q37829812-14B3264D-427F-4ABD-8C7C-5A09605BE6F4
Dimensions author ID	wds:Q37829812-1648C2BE-FE5C-46BF-B997-375D5D7B427A
ORCID iD	https://orcid.org/0000-0003-0626-0834
ORCID iD	0000-0003-0626-0834
Dimensions author ID	01064615503.48
Saxon Academy of Sciences member ID	wds:Q37829812-1B2C5995-3267-4C64-ABFB-BD83C26BFFF7
Saxon Academy of Sciences member ID	hochhausa
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37829812
is author of	Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Should a platelet limit of 600 x 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software